Immediate Impact
63 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
2024 Standout
Works of Julie Simon being referenced
CSF and Blood Levels of GFAP in Alexander Disease
2015
Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Julie Simon | 63 | 78 | 229 | 117 | 94 | 8 | 405 | |
| MA Cleary | 37 | 60 | 253 | 111 | 35 | 9 | 349 | |
| Minke H. de Ru | 86 | 48 | 327 | 156 | 25 | 9 | 398 | |
| Jessica de Ruijter | 62 | 68 | 322 | 160 | 32 | 11 | 394 | |
| Patrick A. Lundquist | 105 | 125 | 236 | 49 | 40 | 16 | 423 | |
| C. Iturriaga | 64 | 183 | 191 | 72 | 42 | 8 | 455 | |
| Toju Tanaka | 42 | 98 | 265 | 117 | 26 | 16 | 407 | |
| Dyane Auclair | 52 | 60 | 335 | 153 | 22 | 13 | 381 | |
| Chuan‐Hong Kao | 50 | 155 | 199 | 102 | 26 | 10 | 401 | |
| Jason S. Weisstein | 10 | 117 | 188 | 65 | 43 | 10 | 419 | |
| N. Leslie | 45 | 120 | 161 | 50 | 19 | 14 | 384 |
All Works
Loading papers...